阑尾病变内镜黏膜下剥离术可行且安全:一项回顾性多中心研究(附视频)
该回顾性多中心研究基于前瞻性登记数据库,收集112例阑尾肿瘤内镜黏膜下剥离术(ESD)资料,整块切除率86.6%、R0切除率80.4%、治愈性切除率78.6%,16例(14.3%)追加手术,作者认为对相当比例患者ESD是潜在更安全有效的替代手术方案。
要点
- 112例阑尾病变ESD中整块切除率86.6%、R0切除率80.4%、治愈性切除率78.6%。
- 16例(14.3%)追加手术,其中Toyonaga 3型10例(62.5%),与追加手术相关(P = .04)。
- 延迟性穿孔5例(4.5%)、急性阑尾炎1例;作者认为对相当比例患者ESD是潜在更安全有效的替代手术方案。
核心结论
- 作者认为,对相当比例患者,阑尾病变ESD是潜在更安全、有效的替代手术方案。
研究设计与样本
- 回顾性多中心研究,数据来自多中心前瞻性登记数据库,收集阑尾肿瘤ESD操作资料。
- 共纳入112例患者,其中47例(42%)有既往阑尾切除史。
- 56例(50%)为Toyonaga 3型病变,其中15例(13.4%)为阑尾切除术后。
主要发现
- 整块切除率为86.6%,R0切除率为80.4%。
- 整块切除率与R0切除率在不同程度阑尾浸润间无显著差异(分别为P = .9和P = .4),与既往阑尾切除史亦无显著差异(两者P = .3)。
- 治愈性切除率为78.6%。
- 16例(14.3%)追加手术,包括10例(62.5%)Toyonaga 3型病变(P = .04)。
- 追加手术包括处理5例(4.5%)延迟性穿孔和1例急性阑尾炎。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) is challenging for appendicular lesions. We report the outcomes of ESD in this context. METHODS: We collected data of ESD procedures for appendiceal neoplasia in a multicenter prospective registry. Main study endpoints were R0, en-bloc, and curative resection rates and adverse event rate. RESULTS: One hundred twelve patients were included, 47 (42%) with previous appendectomy. Fifty-six (50%) were Toyonaga type 3 lesions (15 [13.4%] postappendectomy). En-bloc and R0 resection rates were 86.6% and 80.4%, respectively, with no significant difference associated with different grades of appendiceal invasion (P = .9 and P = .4, respectively) or previous appendectomy (P = .3 for both). The curative resection rate was 78.6%. Additional surgery was performed in 16 cases (14.3%), including 10 (62.5%) Toyonaga type 3 lesions (P = .04). This included the treatment of 5 cases (4.5%) of delayed perforation and 1 acute appendicitis. CONCLUSIONS: ESD for appendicular lesions is a potentially safer and effective alternative to surgery for a significant proportion of patients.
引用
- Figueiredo M, Yzet C, Wallenhorst T, et al. Endoscopic submucosal dissection of appendicular lesions is feasible and safe: a retrospective multicenter study (with video). Gastrointest Endosc. 2023. PMID: 37380005. doi:10.1016/j.gie.2023.06.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。